Skip to content
Scb logo white
Scb logo color
  • Home
  • About
  • Platform
  • Pipeline
  • Collaborations
  • News
  • Careers
  • Contact

News Release

National institute small News Release
News Release

Scenic Biotech Enters Cooperative Research and Development Agreement with the National Institutes of Health for Genetic Modifier-Based Treatment Approach for Niemann-Pick Type C Disease

Picture website News Release
News Release

Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to Find Tailored Treatment for the Complex Rare Disease

Rene van den oever News Release
News Release

Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases

News 3@3x News Release
News Release

Scenic Biotech Appoints Jens Würthner as Chief Medical Officer

News 2@3x News Release
News Release

Scenic Biotech Strengthens Drug Discovery Expertise in Management Team with the Addition of Kristof Van Emelen

Phillipe dro (1) News Release
News Release

Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman

Genentech News Release
News Release

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech

Izeboud oscar 1200 News Release
News Release

Scenic Biotech Appoints Oscar Izeboud as Chief Executive Officer

Rene van den oever News Release
News Release

Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program

Network News Release
News Release

Scenic’s platform technology patent receives notice of allowance

HOME ABOUT PLATFORM PIPELINE COLLABORATIONS NEWS CAREERS CONTACT

© Scenic Biotech 2025

Privacy Policy Disclaimer Cookies

Webdesign by Marsmedia


Linkedin icon

Manage Consent
We use cookies to optimize our website and our service.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}